RE:Tomorrow is Rare Disease Day...@BioasisUS says, "As we approach #RareDiseaseDay, we're reminded of the need for innovative treatments for these often-neglected conditions. At Bioasis, we're proud to be working towards that goal by developing cutting-edge therapies for rare brain disorders.
Bwah hahahaha!
Yes, Bioasis does need to be reminded of the need for blah blah blah...
What a
smarmy response!
Bioasis has purposefully played down what could be one of the most valuable tools in the treatment of CNS rare diseases, xB3. The company's share price has dropped over 95% since Dr. Deborah Rathjen became CEO.
But you know, I'll bet that Rathjen believes that post she made on Twitter.
We know poof believes it.
1.5¢ !! jd